We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+14.58%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$378M
AUM Growth
+$22.7M
Cap. Flow
-$2.63M
Cap. Flow %
-0.7%
Top 10 Hldgs %
31.74%
Holding
97
New
18
Increased
35
Reduced
31
Closed
13

Top Buys

Rank Stock Value
1
MASI
Masimo
MASI
+$7.85M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$5.39M
3
IMUX icon
Immunic
IMUX
+$4.26M
4
ETNB
89bio
ETNB
+$3.49M
5
SDC
SmileDirectClub, Inc. Class A Common Stock
SDC
+$3.31M

Top Sells

Rank Stock Value
1
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$8.03M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$6.37M
3
GNMK
GenMark Diagnostics, Inc
GNMK
+$4.89M
4
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$3.45M
5
NVAX icon
Novavax
NVAX
+$2.74M

Sector Composition

Rank Sector Weight
1 Healthcare 92.08%
2 Technology 1.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLRN
26
DELISTED
Acceleron Pharma
XLRN
$5.63M 1.49%
50,016
-7,484
-13% -$745K
KOD icon
27
Kodiak Sciences
KOD
$2.72B
$5.49M 1.45%
92,733
+27,515
+42% +$1.38M
TRIL
28
DELISTED
Trillium Therapeutics Inc.
TRIL
$5.33M 1.41%
375,063
+75,063
+25% +$748K
NUAN
29
DELISTED
Nuance Communications, Inc.
NUAN
$5.31M 1.41%
160,075
+35,019
+28% +$1.02M
IMVT icon
30
Immunovant
IMVT
$8.8B
$5.28M 1.4%
150,151
+25,026
+20% +$753K
SPNE
31
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$5.27M 1.4%
368,813
+123,028
+50% +$1.49M
XENE icon
32
Xenon Pharmaceuticals
XENE
$6.31B
$5.15M 1.36%
464,825
-125,442
-21% -$1.48M
ICAD
33
DELISTED
iCAD Inc
ICAD
$5.13M 1.36%
581,752
-143,838
-20% -$1.42M
GWPH
34
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$4.87M 1.29%
50,000
-69,778
-58% -$8.03M
ACRS icon
35
Aclaris Therapeutics
ACRS
$860M
$4.74M 1.25%
1,842,661
+145,304
+9% +$325K
KRMD icon
36
KORU Medical Systems
KRMD
$152M
$4.56M 1.21%
631,226
-90,759
-13% -$805K
ALNY icon
37
Alnylam Pharmaceuticals
ALNY
$30B
$4.49M 1.19%
30,863
-5,000
-14% -$711K
SDC
38
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$4.21M 1.11%
+360,000
New +$3.31M
RCUS icon
39
Arcus Biosciences
RCUS
$3.69B
$4.03M 1.07%
235,038
+75,038
+47% +$1.68M
ZYME icon
40
Zymeworks
ZYME
$1.77B
$3.96M 1.05%
+85,000
New +$2.92M
CDMO
41
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$3.69M 0.98%
484,247
+359,247
+287% +$2.72M
KDMN
42
DELISTED
Kadmon Holdings, Inc.
KDMN
$3.43M 0.91%
875,150
+150,150
+21% +$631K
ATEC icon
43
Alphatec Holdings
ATEC
$1.49B
$3M 0.79%
451,672
+25,073
+6% +$141K
INFU icon
44
InfuSystem Holdings
INFU
$244M
$2.99M 0.79%
232,935
+17,452
+8% +$227K
IDXX icon
45
Idexx Laboratories
IDXX
$45B
$2.95M 0.78%
+7,500
New +$2.77M
MTEM
46
DELISTED
Molecular Templates, Inc.
MTEM
$2.93M 0.77%
17,863
-4,995
-22% -$888K
BBIO icon
47
BridgeBio Pharma
BBIO
$16.4B
$2.82M 0.75%
75,228
+13
+0% +$409
ETNB
48
DELISTED
89bio
ETNB
$2.82M 0.75%
+110,000
New +$3.49M
BCRX icon
49
BioCryst Pharmaceuticals
BCRX
$2.71B
$2.75M 0.73%
800,740
-99,868
-11% -$428K
MRSN
50
DELISTED
Mersana Therapeutics
MRSN
$2.61M 0.69%
5,603
-4,397
-44% -$2.22M
1
2
3 4

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Parkman Healthcare Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Parkman Healthcare Partners held 97 positions worth $378M, up 6.4% from $355M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Parkman Healthcare Partners's Q3 2020 filing shows 18 new, 35 increased, 31 reduced and 13 closed positions. Its largest new stake was Masimo: 35,000 shares worth $8.26M. The largest sale was GW Pharmaceuticals Plc American Depositary Shares, an estimated $8.03M.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 90% a quarter earlier, followed by Technology.

  • Parkman Healthcare Partners's largest Q3 2020 buy was Masimo: 35,000 shares worth $8.26M.
  • Parkman Healthcare Partners added most to Immunic in Q3 2020, an estimated $4.26M increase.
  • Parkman Healthcare Partners's biggest Q3 2020 reduction was GW Pharmaceuticals Plc American Depositary Shares, cutting an estimated $8.03M.
  • Parkman Healthcare Partners fully exited Seagen Inc. Common Stock in Q3 2020, selling an estimated $6.37M.
  • Parkman Healthcare Partners's ten largest holdings make up 32% of its $378M portfolio in Q3 2020.
  • Parkman Healthcare Partners opened 18 new positions and closed 13 in Q3 2020.
  • Parkman Healthcare Partners's portfolio value rose 6.4% quarter-over-quarter to $378M.

Based on Parkman Healthcare Partners's 13F filing for Q3 2020, filed 13 Nov 2020.